TurnerTrends Stock Rating Report for POSS
Data valid for week beginning May 12, 2008
|
POSS [News]
|
Possis Medical Inc
|
Company Profile
"Possis Medical, Inc. develops, manufactures, and distributes medical devices, primarily targeting catheter-based therapies for the treatment of vascular disorders. Its primary product AngioJet Rheolytic Thrombectomy System, a non-surgical, minimally invasive catheter system, which is used to remove blood clots from arteries, veins, and grafts. The company markets the XMI (Over the Wire version - OTW), XMI-RX (Rapid Exchange version), XMI RX +, Spiroflex, XVG(R), Spiroflex VG, Xpeedior, DVX, and AVX lines of catheters. It also markets various non-AngioJet products, including the SafeSeal Hemostasis Patch, which is used to control bleeding from the puncture made to perform an endovascular procedure: and Fetch Aspiration Catheter for general arterial use and specifically for use in coronary arteries. In addition, Possis Medical develops the .035 GuardDOG Occlusion Guidewire System, which is designed to temporarily occlude blood flow through the treatment field during vascular interventions and a companion .014 guidewire. Further, the company, through its investment in Rafael Medical Technologies, Inc., develops an inferior vena cava filter named SafeFlo. It offers its products primarily to interventional cardiologists, interventional radiologists, and vascular surgeons, as well as to physician specialty groups, such as nephrologists and osteopaths in the United States, Germany. Possis Medical was founded in 1952 and is headquartered in Minneapolis, Minnesota."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Latest News
| News provided by Yahoo! Finance |
|
